Bristol Myers Squibb

OPDUALAG - Cost

Last Updated: April 1st, 2024

HCPCS:

J9298

HCPCS Code Descriptor:

Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg

Medicare Payment Limit:

The OPDUALAG Medicare Payment Limit is $187.003

Average Sale Price:

OPDUALAG ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The OPDUALAG Medicare Co-insurance percentage is 20%. OPDUALAG's Medicare Co-insurance amount is $37.4 per HCPCS unit.

APC Code:

The Opdualag APC Code is: 9057

APC Payment Limit:

The APC Payment Limit for OPDUALAG is available. Login to view.

Opdualag Cost Information:

Opdualag is aligned to the J Code J9298, which became effective in October of 2022. Opdualag has taken incremental price increases every six months since its effective date. These price increases have historically occurred in January and July. Opdualag average sales price was published in October 2022, the same time that its HCPCS became effective. The ASP for Opdualag has remained close to its WAC price, indicating a lack of significant discounting.

ACCESS PRICING AND MORE BY REGISTERING

Opdualag’s wholesale acquisition cost (WAC) information was last updated on:
January 1, 2024
Opdualag’s average wholesale price (AWP) information was last updated on:
January 1, 2024